The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that uses an adeno-associated viral vector to treat spinal muscular atrophy (SMA) ...

Itvisma's approval is a strategic milestone within the Emirates Drug Establishment's mission to position the UAE as a regional hub for pharmaceutical innovation by delivering advanced genetic ...

Quebec, Canada, December 20th, 2025, FinanceWireInternational clinician and integrative health researcher Oxana Ali has ...

U.S. Health Secretary Robert F. Kennedy Jr. on Tuesday added two rare genetic disorders, Duchenne Muscular Dystrophy and ...

BSSC released the Bihar Sports Trainer Syllabus and Exam Pattern. Check the latest BSSC Sports Trainer Syllabus for all ...

Teuta Hoxha says she remains determined despite growing fears for her health and five other prisoners staging protest ...

Determining which patients should receive the treatment will still require individual risk-benefit assessments, experts say.

Discusses HOPE-3 Phase III Trial Results and Regulatory Path for Duchenne Muscular Dystrophy Therapy December 17, ...

The Emirates Drug Establishment (EDE) has announced the approval of Itvisma (onasemnogene abeparvovec), a gene therapy that ...

The immune system operates as a muscular system, which becomes more powerful through regular activation. White blood cells ...

Neuroscience now provides substantial evidence that meditation leads to measurable changes in brain structure and function, a ...

Aging taps us on the shoulder in many ways: wrinkles, thinning hair, loss of flexibility, slowing of the brain. But the ...